James Cloyd III, Pharm D, Morse Alumni Distinguished Teaching Professor of Pharmacy and Neurology, the Lawrence C. Weaver Endowed Chair in Orphan Drug Development, and Director of the Center for Orphan Drug Research at the University of Minnesota College of Pharmacy.

Dr. Cloyd’s research focuses on the clinical pharmacology of CNS drugs. His research includes laboratory investigations of drug solubility, stability, and pharmacology; pharmacokinetic and efficacy studies in animals; drug safety, bioavailability and pharmacokinetic, pharmacogenomic, drug interaction, and efficacy studies in healthy volunteers and/or patients including children and the elderly. He holds 9 INDs and has served as principal or co-principal investigator for several Phase I-Phase III trials, many of which have supported NDA applications.

He has been a member of several National Institute of Neurological Disorders and Stroke (NINDS) data and safety monitoring boards, has served on the NINDS clinical trials study section, and is a temporary voting member of the FDA Advisory Committee on Pharmaceutical Science and Clinical Pharmacology.

Daniel Friedman MD, MSc, Associate Professor of Neurology at NYU Langone Health. His expertise includes epilepsy, clinical trial methodology, novel trial designs, and outcomes research.

Dr. Friedman is also the co-director of the video-EEG (electroencephalography) laboratory at NYU Langone Health. Dr. Friedman specializes in the treatment of teenagers and adults with difficult to control epilepsy. He also performs research to better understand the causes of morbidity and mortality of epilepsy and test interventions to improve outcomes.

He serves on the executive committees of the North American SUDEP (sudden unexpected death in epilepsy) Registry and the Epilepsy Study Consortium. He also serves on the professional advisory board of the Epilepsy Foundation.

Brian Hainline, MD, Chief Medical Officer, the National Collegiate Athletic Association, and Clinical Professor of Neurology at Indiana University School of Medicine and NYU School of Medicine. He is an expert in pain management, concussion and sports medicine.

Dr. Hainline serves as the NCAA’s first chief medical officer, where he oversees the NCAA Sport Science Institute, which works collaboratively with member institutions and Centers of Excellence across the United States.

For more than 25 years, Dr. Hainline has been actively involved in sports medicine. He co-authored “Drugs and the Athlete,” and played a pivotal role in the development of drug testing and education protocols worldwide. He has served on the New York State Athletic Commission and the USOC Sports Medicine Committee and is a founding member of the executive committee of the American Academy of Neurology Sports Neurology Section that he currently chairs.

At the NCAA, Dr. Hainline developed, in partnership with the Department of Defense, the NCAA-DoD Grand Alliance, which includes the CARE Consortium, a multimillion-dollar study that aims to understand the natural history of concussion and neurobiological recovery in concussion. Dr. Hainline has taken a leadership role in addressing other pressing issues of student-athletes, including mental health, overuse injuries, alcohol and drug abuse, and sudden cardiac death.

Richard B. Lipton, MD, Edwin S. Lowe Professor and Vice Chair of Neurology, Professor of Epidemiology and Population Health and Professor of Psychiatry and Behavioral Sciences at the Albert Einstein College of Medicine. He directs the Montefiore Headache Center.

Dr. Lipton earned his medical degree at the University of Chicago Pritzker School of Medicine.

After a medical internship at Northwestern Memorial Hospital, he completed his neurology residency and clinical neurophysiology fellowship at the Albert Einstein College of Medicine. He also completed a fellowship in neuroepidemiology at Columbia University. He is a diplomate of the American Board of Psychiatry and Neurology and a fellow of the American Academy of Neurology.

His research focuses on cognitive aging, Alzheimer’s disease and migraine headaches. He is the Principal Investigator of the Einstein Aging Study, an NIH funded Program Project. His research focuses on risk factors and biomarkers of cognitive decline and Alzheimer’s disease. His recent studies examine cognitive aging across the lifespan with an emphasis on the effects of pain and stress on brain function.

His headache research focuses on the epidemiology of migraine and on clinical trials. His epidemiologic studies have evaluated trigger factors for headache attacks and risk factors for headache progression. Dr. Lipton has published more than 800 original articles, many with trainees. He is a five-time winner of the H.G. Wolff Award for excellence in headache research from the American Headache Society and a two-time winner of the Enrico Greppi award from the European Headache Federation. Dr. Lipton is Director of the Montefiore Headache Center, an interdisciplinary subspecialty center focused on headache, patient care, research and education.

Charles R. Marmar, MD, Lucius N. Littauer Professor and Chair of the Department of Psychiatry at NYU Langone Health. Dr. Marmar directs the NYU Center for the Study of Alcohol Use Disorder and Posttraumatic Stress Disorder. He is an international expert in anxiety disorders, PTSD, and mental health in veterans.

Dr. Marmar previously served as Professor and Vice Chair at the University of California, San Francisco (UCSF), and the Associate Chief of Staff for Mental Health and Director of the Posttraumatic Stress Disorder (PTSD) Research Program at the San Francisco Veterans Affairs Medical Center.

Internationally-renowned for his expertise in PTSD, Dr. Marmar's focus has ranged from combat-related conditions in veterans, including those from Iraq and Afghanistan, to groups as disparate as refugees and earthquake victims. He has served on multiple committees and scientific advisory groups at the national level, for both the Veteran's Administration in Washington, D.C., and for the National Institute of Mental Health.

An award-winning teacher and researcher who chaired his department's Research and Education Track at UCSF and directed a VA Neuroscience Research Fellowship program, Dr. Marmar is currently the principal investigator of seven PTSD-related grants funded by the National Institute on Alcohol Abuse and Alcoholism, the Department of Defense, Bank of America Foundation and Brockman Foundation.